75fbd7b2-figure-02 (75fbd7b2 Figure 02)
Diltiazem Hydrochloride Capsule, Extended Release
Product Images NDC 55154-4321
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Diltiazem Hydrochloride (NDC 55154-4321). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Structural Formula (E7476adc A940 4e76 A1dd C418de493bc0 02)
Bag Label (Image 01)
Bag Label (Image 02)
This text is a description of a medication called Diltiazem HCl Extended-Release Capsules, USP 180mg. It is a once-a-day dosage medication used for certain medical conditions. The usual dosage and precautions can be found in the product insert available on the website www.majorpharmaceuticals.com. The medication should be stored at a temperature between 20°C and 25°C, avoiding excessive humidity. It is important to keep this medication and all drugs out of the reach of children. The medication is dispensed in a tight, light-resistant container and is intended for institutional use only. The manufacturer is TWi Pharmaceuticals, Inc. in Taoyuan City, Taiwan, and it is manufactured for TWi Pharmaceuticals USA, Inc. in Paramus, NJ. The packaging and distribution are done by MAJOR® PHARMACEUTICALS in Indianapolis, IN, with distribution support from Cardinal Health in Dublin, OH.*
Bag Label (Image 03)
Not available*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
